Your browser doesn't support javascript.
loading
Synergistic antitumor response with recombinant modified virus Ankara armed with CD40L and CD137L against peritoneal carcinomatosis.
Bella, Ángela; Arrizabalaga, Leire; Di Trani, Claudia Augusta; Cirella, Assunta; Fernandez-Sendin, Myriam; Gomar, Celia; Russo-Cabrera, Joan Salvador; Rodríguez, Inmaculada; González-Gomariz, José; Alvarez, Maite; Teijeira, Álvaro; Medina-Echeverz, José; Hinterberger, Maria; Hochrein, Hubertus; Melero, Ignacio; Berraondo, Pedro; Aranda, Fernando.
Afiliação
  • Bella Á; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.
  • Arrizabalaga L; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.
  • Di Trani CA; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.
  • Cirella A; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.
  • Fernandez-Sendin M; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.
  • Gomar C; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.
  • Russo-Cabrera JS; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.
  • Rodríguez I; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.
  • González-Gomariz J; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.
  • Alvarez M; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.
  • Teijeira Á; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.
  • Medina-Echeverz J; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.
  • Hinterberger M; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.
  • Hochrein H; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.
  • Melero I; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.
  • Berraondo P; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.
  • Aranda F; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.
Oncoimmunology ; 11(1): 2098657, 2022.
Article em En | MEDLINE | ID: mdl-35859732
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Peritoneais / Vacínia / Ligante 4-1BB Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Peritoneais / Vacínia / Ligante 4-1BB Idioma: En Ano de publicação: 2022 Tipo de documento: Article